Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OGN Organon & Co

交易中 08-16 10:15:35 EDT

20.13

+0.19

+0.95%

最高20.17	最低19.76	成交量8.51万
今开19.88	昨收19.94	日振幅2.06%
总市值51.83亿	流通市值51.67亿	总股本2.57亿
成交额170.45万	换手率0.03%	流通股本2.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":20.13,"timestamp":1723817733096,"preClose":19.94,"halted":0,"volume":85135,"delay":0,"floatShares":256695778,"shares":257473477,"eps":3.87624,"marketStatus":"交易中","marketStatusCode":2,"change":0.19,"latestTime":"08-16 10:15:35 EDT","open":19.88,"high":20.17,"low":19.76,"amount":1704510.3957749999,"amplitude":0.020562,"askPrice":20.13,"askSize":201,"bidPrice":20.11,"bidSize":2,"shortable":3,"etf":0,"ttmEps":3.87624,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1723838400000},"adr":0,"adjPreClose":19.94,"dividendRate":0.055638,"preHourTrading":{"tag":"盘前","latestPrice":19.9,"preClose":19.94,"latestTime":"08:55 EDT","volume":19,"amount":380.29999100000003,"timestamp":1723812914052},"postHourTrading":{"tag":"盘后","latestPrice":20.22,"preClose":20.22,"latestTime":"19:58 EDT","volume":27903,"amount":564209.07,"timestamp":1723766308522},"volumeRatio":0.482744,"impliedVol":0.3617,"impliedVolPercentile":0.127},"requestUrl":"/m/hq/s/OGN","defaultTab":"news","newsList":[{"id":"2458469739","title":"Organon & Co.2024财年第二财季实现净利润1.95亿美元，同比减少19.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458469739","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458469739?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:14","pubTimestamp":1723392890,"startTime":"0","endTime":"0","summary":"8月12日，Organon & Co.公布财报，公告显示公司2024财年第二财季净利润为1.95亿美元，同比减少19.42%；其中营业收入为16.07亿美元，同比减少0.06%，每股基本收益为0.76美元。从资产负债表来看，Organon & Co.总负债120.10亿美元，其中短期债务9.00百万美元，资产负债比为1.02，流动比率为1.64。机构评级：截至2024年8月12日，当前有8家机构对Organon & Co.目标价做出预测，其中目标均价为22.50美元，其中最低目标价为17.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001452959044ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001452959044ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN"],"gpt_icon":0},{"id":"2457422468","title":"Organon & Co.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457422468","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457422468?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:57","pubTimestamp":1723039058,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时57分，Organon & Co.股票出现异动，股价急速上涨5.04%。截至发稿，该股报19.59美元/股，成交量27.7894万股，换手率0.11%，振幅3.54%。Organon & Co.股票所在的制药行业中，整体跌幅为0.50%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215739941ff0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215739941ff0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","BK4007","LU2065170008.USD","OGN","BK4559","BK4588","LU2065171311.SGD","BK4585","LU2065169927.USD"],"gpt_icon":0},{"id":"2457732550","title":"BUZZ--美国股票走势-Lumen Technologies、Broadridge Financial、IDEXX","url":"https://stock-news.laohu8.com/highlight/detail?id=2457732550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457732550?lang=zh_cn&edition=full","pubTime":"2024-08-07 00:30","pubTimestamp":1722961818,"startTime":"0","endTime":"0","summary":"美东时间12:14，道琼斯工业平均指数  上涨1.22%，报39,175.66点。标普500指数  上涨1.74%，报5276.66点；纳斯达克综合指数  上涨1.81%，报16492.856点。** CVS Health Corp   ：下跌 0.5%BUZZ - 巴克莱认为，成本上升趋势对 CVS 第二季度和全年利润构成风险   ** Jacobs Solutions Inc   ：上涨 1.2%BUZZ - 在第三季度收入超预期后上涨   ** IDEXX Laboratories Inc   ：上涨 4.3%BUZZ - 在预期下调并不像人们担心的那样糟糕之后，在缓解性反弹中上涨   标准普尔 500 指数的 11 个主要行业：通信服务","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TALK","QID","GEHC","BR","LUMN","BUZZ",".SPX","PSQ","VNO","DXD","IDXX","TAP","SQQQ","DDM","EXPD","UDOW","HSIC","FIS","BVS","TDG",".IXIC","BMRN","HIMS","TQQQ","CVS","MNQmain","ZI","ZTS","KVUE","BAX","MPC","DJX","ELEV","NQmain","CAT","J","MCK","MKTX","CSX","SDOW",".DJI","SPWR","OGN","SRPT"],"gpt_icon":1},{"id":"2457023094","title":"BUZZ-Organon & Co 因下调财年销售预期而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023094","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023094?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:01","pubTimestamp":1722952888,"startTime":"0","endTime":"0","summary":"    8月6日 - ** 专注于女性健康的 Organon    股价下跌 9%，报 18.31 美元** 公司目前预计全年收入在62.5亿至64.5亿美元之间，而之前的预期为62亿至65亿美元。** Organon 公布第二季度收入为 16.1 亿美元，预计为 16.3 亿美元。** 公司妇女保健产品的销售额增长 3%，达到 4.49 亿美元，与预期一致 ** Organon 既有品牌部门和生物仿制药业务的收入低于预期** 截至上一交易日收盘，股价累计上涨 40","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4007","OGN","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","LU2065171311.SGD","BK4559","BUZZ"],"gpt_icon":0},{"id":"1152349908","title":"异动解读 | Organon & Co二季度业绩不佳 股价盘中大跌7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152349908","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152349908?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:43","pubTimestamp":1722951811,"startTime":"0","endTime":"0","summary":"制药公司Organon & Co今日公布了2024年第二季度财报,业绩数据令人失望,导致其股价盘中大跌7.38%。\n\n财报显示,Organon & Co本季度调整后每股收益为1.12美元,低于去年同期的1.31美元。营业收入为16.1亿美元,同比下降0.1%,也未能达到分析师预期的16.3亿美元。公司本季度净收入为1.95亿美元,较上年同期有所下降。\n\n值得注意的是,在过去三个月里,分析师对Organon & Co的平均盈利预期下调了约6.3%,显示出对公司未来前景的担忧。目前分析师对该公司股票的平均评级为\"持有\"。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"gpt_icon":0},{"id":"2457400330","title":"Organon & Co 公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457400330","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457400330?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:32","pubTimestamp":1722951178,"startTime":"0","endTime":"0","summary":"   * Organon & Co   公布的截至6月底的季度调整后每股收益为1.12美元，低于去年同期的每股收益1.31美元。八位分析师对该季度的平均预期为每股收益 1.08 美元。华尔街预期为每股收益 93 美分至 1.24 美元。* Organon & Co 公司公布的本季度每股收益为 75 美分。* 公司报告的季度净收入为 1.95 亿美元。* Organon & Co 的股价本季度下跌了 2.5%，今年迄今为止上涨了 40.0%。华尔街对 Organon & Co 的 12 个月目标价中位数为 22.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Organon & Co 公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4559","OGN","BK4585","LU2065169927.USD","LU2065171402.SGD","LU2065170008.USD","LU2065171311.SGD","BK4007"],"gpt_icon":0},{"id":"2457028730","title":"Organon & Co.盘中异动 大幅下跌5.40%报19.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457028730","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457028730?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:32","pubTimestamp":1722951141,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时32分，Organon & Co.股票出现异动，股价快速下跌5.40%。截至发稿，该股报19.10美元/股，成交量8.1822万股，换手率0.03%，振幅3.37%。Organon & Co.股票所在的制药行业中，整体涨幅为0.90%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213221aefd8581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213221aefd8581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN","BK4588","LU2065171311.SGD","BK4559","LU2065170008.USD","BK4585","BK4007","LU2065169927.USD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2456237521","title":"Organon & Co   预计每股收益1.08美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456237521","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456237521?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:44","pubTimestamp":1722617062,"startTime":"0","endTime":"0","summary":"   * Organon & Co    将于8月6日公布截至2024年6月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于新泽西州泽西城的公司的营收将从去年同期的16.1亿美元增至16.31亿美元，增幅为1.4%。* LSEG 的分析师平均预期 Organon & Co 每股收益为 1.08 美元。* 华尔街对 Organon & Co 的 12 个月目标价中值为 22.00 美元，高于其上一次收盘价 21.65 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Organon & Co   预计每股收益1.08美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"gpt_icon":0},{"id":"2456153236","title":"Organon & Co.盘中异动 早盘快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456153236","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456153236?lang=zh_cn&edition=full","pubTime":"2024-08-02 23:21","pubTimestamp":1722612118,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日23时21分，Organon & Co.股票出现波动，股价急速下跌5.01%。截至发稿，该股报20.57美元/股，成交量43.2609万股，换手率0.17%，振幅4.30%。Organon & Co.股票所在的制药行业中，整体跌幅为2.21%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802232158aefcfc5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802232158aefcfc5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4559","OGN","BK4585","LU2065169927.USD","LU2065171402.SGD","LU2065170008.USD","LU2065171311.SGD","BK4007"],"gpt_icon":0},{"id":"2450391818","title":"Organon & Co.盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450391818","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450391818?lang=zh_cn&edition=full","pubTime":"2024-07-12 02:07","pubTimestamp":1720721246,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日02时07分，Organon & Co.股票出现波动，股价大幅拉升5.07%。截至发稿，该股报20.93美元/股，成交量87.1328万股，换手率0.34%，振幅3.92%。Organon & Co.股票所在的制药行业中，整体跌幅为0.30%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712020726941f657a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712020726941f657a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","LU2065169927.USD","BK4585","BK4559","LU2065171311.SGD","OGN","LU2065170008.USD","BK4588","BK4007"],"gpt_icon":0},{"id":"2437087237","title":"复宏汉霖与Organon合作取得新进展 第6款申报上市产品HLX14获欧洲药品管理局受理今日，复宏汉霖(2696.HK)与Organon(NYSE: OGN)共同宣布，在研地舒单抗(Prolia®/Xgeva®)生物类似药HLX14的上市许可申请(MAA)获欧洲药品管理局(EMA)受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2437087237","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437087237?lang=zh_cn&edition=full","pubTime":"2024-05-24 19:03","pubTimestamp":1716548614,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4215","LU2065171311.SGD","MAA","BK1161","LU2065170008.USD","BK4007","NYSE","BK4559","02696","BK4585","LU2065171402.SGD","LU2065169927.USD","OGN","BK4588"],"gpt_icon":0},{"id":"2434589869","title":"Organon & Co.2024财年第一财季实现净利润2.01亿美元，同比增加13.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434589869","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434589869?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:21","pubTimestamp":1715358069,"startTime":"0","endTime":"0","summary":"3月31日，Organon & Co.公布财报，公告显示公司2024财年第一财季净利润为2.01亿美元，同比增加13.56%；其中营业收入为16.22亿美元，同比增加5.46%，每股基本收益为0.79美元。从资产负债表来看，Organon & Co.总负债118.43亿美元，其中短期债务9.00百万美元，资产负债比为1.01，流动比率为1.65。机构评级：截至2024年3月31日，当前有8家机构对Organon & Co.目标价做出预测，其中目标均价为22.50美元，其中最低目标价为16.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110021178af1a93f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110021178af1a93f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN"],"gpt_icon":0},{"id":"2432601098","title":"Organon & Co.盘中异动 早盘急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432601098","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432601098?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:32","pubTimestamp":1714656728,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时32分，Organon & Co.股票出现波动，股价急速上涨5.36%。截至发稿，该股报19.84美元/股，成交量10.9102万股，换手率0.04%，振幅2.18%。Organon & Co.股票所在的制药行业中，整体涨幅为0.16%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502213209861eaae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502213209861eaae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065169927.USD","BK4585","BK4588","OGN","LU2065171311.SGD","BK4559","BK4007","LU2065170008.USD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2432087053","title":"Organon & Co    预计每股收益 93 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432087053","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432087053?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:52","pubTimestamp":1714495966,"startTime":"0","endTime":"0","summary":"   * Organon & Co    将于5月2日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于新泽西州泽西城的公司的营收将从去年同期的15.4亿美元增至15.63亿美元，增幅为1.6%。* LSEG 分析师对 Organon & Co 的平均预期为每股收益 93 美分。* 华尔街对 Organon & Co 的 12 个月目标价中位数为 21.00 美元，高于其上次收盘价 18.90 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"gpt_icon":0},{"id":"2428390560","title":"全国零售药店\"疼痛关爱中心\"建设全面启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2428390560","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428390560?lang=zh_cn&edition=full","pubTime":"2024-04-17 17:48","pubTimestamp":1713347280,"startTime":"0","endTime":"0","summary":"世界痛风日到来之际，由中国健康促进与教育协会主办、欧加隆共同参与的零售药店\"疼痛关爱中心\"建设全国启动会在浙江杭州成功举办。大会的召开，代表着中国健康促进与教育协会发起的\"助力健康中国，关注疼痛疾病管理药师赋能项目\"在2024年的稳步深耕。今天，欧加隆非常荣幸携手主办协会，共同建设一张覆盖全国的零售药店'疼痛关爱中心'专业网络，构建疼痛管理从院内到院外的'全景诊疗'闭环。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4390128_ZH90128_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4585","BK4588","BK4007","OGN","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","LU2065171311.SGD","BK4559"],"gpt_icon":0},{"id":"2428330615","title":"【Origin Protocol通过“合并OGV与OGN”的提案，OGN持有者将从OETH和OUSD的协议收入中获利】金色财经报道，NFT基础设施Origin Protocol宣布已通过“合并OGV与OGN”的提案投票。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428330615","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428330615?lang=zh_cn&edition=full","pubTime":"2024-04-17 10:32","pubTimestamp":1713321124,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"'https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4559","BK4585","LU2065171311.SGD","OGN","LU2065170008.USD","BK4007","LU2065169927.USD","BK4588","BK4141","ARM","LU2065171402.SGD"],"gpt_icon":0},{"id":"2424834097","title":"【Origin提议合并OGN和OGV，并将在其他EVM兼容链上推出原生LST】4月3日消息，LSDFi协议Origin Protocol公布产品路线图和代币经济学改进方案。","url":"https://stock-news.laohu8.com/highlight/detail?id=2424834097","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424834097?lang=zh_cn&edition=full","pubTime":"2024-04-03 11:07","pubTimestamp":1712113656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"'https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4559","LU2065169927.USD","LU2065171402.SGD","BK4588","BK4007","LU2065171311.SGD","LU2065170008.USD","EVM","OGN","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.organon.com","stockEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0284},{"period":"3month","weight":-0.0725},{"period":"6month","weight":0.0807},{"period":"1year","weight":-0.1155},{"period":"ytd","weight":0.4022}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Organon & Co.是一家特拉华州公司，成立于2020年3月11日。Organon是一家基于科学的全球制药公司，通过一系列针对女性健康，生物仿制药和知名品牌的处方疗法，开发并提供创新的健康解决方案。他们的使命是成为世界领先的女性保健公司，每天为每个女性提供更好，更健康的服务。他们计划利用自身在生殖健康方面的优势，建立一系列健康解决方案，为从青春期到更年期及以后的妇女提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.093787},{"month":2,"riseRate":0.666667,"avgChangeRate":0.009437},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.00802},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.012449},{"month":5,"riseRate":0.666667,"avgChangeRate":0.03585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.022403},{"month":7,"riseRate":0.5,"avgChangeRate":0.002701},{"month":8,"riseRate":0.25,"avgChangeRate":-0.00207},{"month":9,"riseRate":0,"avgChangeRate":-0.14058},{"month":10,"riseRate":0.666667,"avgChangeRate":0.03051},{"month":11,"riseRate":0,"avgChangeRate":-0.148452},{"month":12,"riseRate":1,"avgChangeRate":0.129665}],"exchange":"NYSE","name":"Organon & Co","nameEN":"Organon & Co"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Organon & Co,OGN,Organon & Co股票,Organon & Co股票老虎,Organon & Co股票老虎国际,Organon & Co行情,Organon & Co股票行情,Organon & Co股价,Organon & Co股市,Organon & Co股票价格,Organon & Co股票交易,Organon & Co股票购买,Organon & Co股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}